Subdermal Contraceptive Implants Market - Forecast(2022 - 2027)

Report Code: HCR 1408 Report Format: PDF + Excel

Subdermal Contraceptive Implants Market Overview

Subdermal Contraceptive Implants market size was estimated at $780 million in 2020, growing at a CAGR of 3.35% during the forecast period 2021-2026. Subdermal contraceptive implants are those in which a steroid progestin is delivered by polymer capsules or rods implanted beneath the skin. The hormone diffuses slowly and steadily, giving effective contraception for 1 to 5 years. The duration of protection is determined by the type of progestin used and the type of polymer used. Subdermal contraceptive implants are simple to use and provide excellent results. It is a 4-cm single-rod implant that can be put subdermally through a trocar. There are two types of subdermal contraceptive implant such as levonorgestrel implant, and etonogestrel implant. If a female waits more than three years to replace her rod, her chances of becoming pregnant increase. It is a 4-cm single-rod implant that can be put subdermally through a trocar. The disadvantage of the implant is disruption of normal menstruation and an increase in breast pain. The increasing number of unwanted pregnancy and abortion is the major factors driving the growth of the market. Increasing awareness about sexual health and family planning is set to further enhance the overall market development of the Subdermal Contraceptive Implants Market for the period 2021-2026.

Report Coverage

The report: “Subdermal Contraceptive Implants Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Subdermal Contraceptive Implants Market.
By Type: Etonogestrel Implant, and Levonorgestrel Implant
By End-User: Hospitals, Clinics, Diagnostic Centres and Others.
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (Middle East, and Africa)

Key Takeaways

  • North America dominated the Subdermal Contraceptive Implants Market in 2020 owing to the increasing number of abortions in this region. The Subdermal Contraceptive Implants Market scope for different regions will be provided in the final report.
  • Increasing introduction of affordable contraceptives by market players is set to aid the market growth of the Subdermal Contraceptive Implants Market report.
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Subdermal Contraceptive Implants Market report.
  • Side effects of contraceptive implants is poised to create the hurdles for the Subdermal Contraceptive Implants Market.

Subdermal Contraceptive Implants Market Revenue Share, By Geography, 2020(%)

For more details on this report - Request for Sample

Subdermal Contraceptive Implants Market Segment Analysis – By Type

Based on type, the Subdermal Contraceptive Implants market is segmented into Etonogestrel Implant, and Levonorgestrel Implant. Etonogestrel Implant held the largest share and is also estimated to register a higher CAGR of 4.1% during the forecast period 2021-2026. Etonogestrel is a birth control medicine for women. Etonogestrel (a drug type that comes under progestin medical class) is a hormone that inhibits ovulation from taking place. It is offered as an implant that is inserted beneath the skin of the upper arm. The implant is non-biodegradable, off-white, and 4 cm long with a 2 mm diameter. Each implant is made up of an ethylene vinylacetate (EVA) copolymer core containing 68 mg of etonogestrel, a synthetic progestin, and an EVA copolymer skin thereby increasing Subdermal Contraceptive Implants market. 

Subdermal Contraceptive Implants Market Segment Analysis – By Application

On the basis of application market for Subdermal Contraceptive Implants is categorized in Hospitals, Clinics, Diagnostic Centres and Others. Hospitals held the largest share and it is estimated to register a CAGR of 4.3% during the forecast period 2021-2026. Hospitals offer high-traffic environments, advanced healthcare infrastructure, innovative medical equipment and services, and the presence of competent medical experts in hospitals thereby increasing Subdermal Contraceptive Implants market. 

Subdermal Contraceptive Implants Market Segment Analysis – By Geography

North America dominated the Subdermal Contraceptive Implants market with a major share of 57% in 2020. This is attributed to growing research and development activities coupled with establishrd healthcare infrastructure in this region. Furthermore, growing number of abortions and increasing health concerns are contributing to the growth of the market in this region. 

However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2021-2026 owing to rising unwanted pregnancies in this region contribute the growth in this region. The increasing introduction of supportive healthcare programs coupled with rising government initiatives is also increasing the growth of the market in this region. 

Subdermal Contraceptive Implants Market Drivers

Increasing Number of Unwanted Pregnancies.  

The increasing number of unwanted pregnancies leads to rise in abortions and is therefore increasing the growth of the Subdermal Contraceptive Implants Market. According to the World Health Organization's 2019 report, 74 million women in low and middle-income countries experience unwanted pregnancies each year. Every year, this results in 25 million unsafe abortions and 47000 maternal deaths. Additionally, increase in adoption rate of contraceptive drugs is also practiced to increase the growth of the Subdermal Contraceptive Implants market during the forecast period 2021-2026. 

Rising Government Initiatives. 

Increasing government initiatives to spread awareness about unwanted abortions and pregnancies is increasing the growth of the Subdermal Contraceptive Implants market. Certain countries and their governments have recognised the need to reduce the number of unwanted pregnancies and have launched a projects to educate and prevent the spread of unwanted pregnancies and abortions. For Instance, FDA-approved birth control products are covered by Medicaid and other insurance plans without cost sharing thereby increasing the growth of the Subdermal Contraceptive Implants Market during the forecast period 2021-2026.

Subdermal Contraceptive Implants Market Challenges

Side Effects

Major factor that is set to impede the growth of the Subdermal Contraceptive Implants market is side effects of subdermal contraceptive implants are disruption of normal menstruation and increase in breast pain. Another factor which hamper the growth of market is increasing rate of infertility.

Subdermal Contraceptive Implants Market Landscape

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Subdermal Contraceptive Implants Market. In 2020, the Subdermal Contraceptive Implants Market share is consolidated by the top ten players present in the market. The Subdermal Contraceptive Implants Market, top 10 companies are, Bayer AG, Shanghai Dahua Pharmaceutical Co., Ltd., Merck Sharp & Dohme Corp., Karex Industries, Teva Pharmaceutical Industries Ltd., Allergan plc, The Female Health Company, Reckitt Benckiser Group plc, KESSEL medintim GmbH and Mayer Laboratories. 

Subdermal Contraceptive Implants Market Development: 

  • In November 2020, Karex Industries acquired 30% stake in US based global protection Corp (GP) for RM42.26 million. This acquisition will expand its own brand manufacturing business.

Relevant Titles:
Report Code: HCR 1300

Report Code: HCR 0370

For more Lifesciences and Healthcare related reports, please click here
1. Subdermal Contraceptive Implants Market - Overview
    1.1 Definitions and Scope
2. Subdermal Contraceptive Implants Market - Executive Summary
    2.1 Market Revenue and Key Trends
    2.2 Key trends by Type
    2.3 Key trends by End User
    2.4 Key trends by Geography
3. Subdermal Contraceptive Implants Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis- Average Selling Price
4. Subdermal Contraceptive Implants Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Subdermal Contraceptive Implants Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Subdermal Contraceptive Implants Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Subdermal Contraceptive Implants Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Subdermal Contraceptive Implants Market – By Type(Market Size –$Million/$Billion)
    8.1 Etonogestrel Implant
    8.2 Levonorgestrel Implant
9. Subdermal Contraceptive Implants Market - By End User (Market Size –$Million/$Billion)
    9.1 Hospitals
    9.2 Clinics
    9.3 Diagnostic Centres
    9.4 Others
10. Subdermal Contraceptive Implants Market - By Geography(Market Size –$Million/$Billion)
    10.1 North America
        10.1.1 U.S.
        10.1.2 Mexico
        10.1.3 Canada
    10.2 Europe
        10.2.1 U.K.
        10.2.2 France
        10.2.3 Germany
        10.2.4 Italy
        10.2.5 Spain
        10.2.6 Russia
        10.2.7 Rest of Europe
    10.3 Asia Pacific
        10.3.1 China
        10.3.2 India
        10.3.3 Japan
        10.3.4 South Korea
        10.3.5 Australia & New Zealand
        10.3.6 Rest of APAC
    10.4 South America
        10.4.1 Brazil
        10.4.2 Argentina
        10.4.3 Others
    10.5 Rest of the World
        10.5.1 Middle East
        10.5.2 Africa
11. Subdermal Contraceptive Implants Market - Entropy
12. Subdermal Contraceptive Implants Market – Industry/Segment Competition Landscape Premium
    12.1 Market Share Analysis
        12.1.1 Global Market Share – Key Companies
        12.1.2 Market Share by Region – Key companies
        12.1.3 Market Share by Countries – Key Companies
        12.1.4 Competition Matrix
        12.1.5 Best Practices for Companies
13. Subdermal Contraceptive Implants Market – Key Company List by Country Premium Premium
14. Subdermal Contraceptive Implants Market Company Analysis (Company Revenue, Product, M&A, Developments)
    14.1 Company 1
    14.2 Company 2
    14.3 Company 3
    14.4 Company 4
    14.5 Company 5
    14.6 Company 6
    14.7 Company 7
    14.8 Company 8
    14.9 Company 9
    14.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.